Macquarie Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-761,740	Closed	-$15M	–	1002
2025 Q3	$15M	Sell	761,740 -143,545	-16%	-$2.95M	0.02%	728
2025 Q2	$19.6M	Sell	905,285 -29,327	-3%	-$692K	0.02%	673
2025 Q1	$22.7M	Buy	934,612 +251,960	+37%	+$5.67M	0.03%	629
2024 Q4	$14.2M	Buy	+682,652	New	+$14.7M	0.02%	733
2022 Q4	–	Sell	-186,900	Closed	-$2.42M	–	1892
2022 Q3	$2.42M	Sell	186,900 -2,011	-1%	-$23.8K	﹤0.01%	1164
2022 Q2	$1.32M	Hold	188,911	–	–	﹤0.01%	1410
2022 Q1	$1.57K	Sell	188,911 -600	-0.3%	-$4.24K	﹤0.01%	1441
2021 Q4	$1.28M	Sell	189,511 -23,495	-11%	-$154K	﹤0.01%	1505
2021 Q3	$1.13M	Buy	213,006 +2,200	+1%	+$12K	﹤0.01%	1557
2021 Q2	$1.21M	Buy	210,806 +85,216	+68%	+$440K	﹤0.01%	1559
2021 Q1	$579K	Sell	125,590 -9,237	-7%	-$36.7K	﹤0.01%	1503
2020 Q4	$451K	Hold	134,827	–	–	﹤0.01%	1468
2020 Q3	$401K	Buy	134,827 +112,073	+493%	+$438K	﹤0.01%	1449
2020 Q2	$105K	Buy	+22,754	New	+$102K	﹤0.01%	1736
2018 Q1	–	Sell	-2,100	Closed	-$8K	–	2204
2017 Q4	$8K	Buy	+2,100	New	+$6.94K	﹤0.01%	2303